{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:23:14Z","timestamp":1794090194359,"version":"4.8.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32161133003"],"award-info":[{"award-number":["32161133003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2024AFA093"],"award-info":[{"award-number":["2024AFA093"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB0490000"],"award-info":[{"award-number":["XDB0490000"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.antiviral.2026.106537","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:34:41Z","timestamp":1790033681000},"page":"106537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A self-adjuvant trivalent T4 bacteriophage nanoparticle vaccine induces broad protective immunity against Orthoebolaviruses"],"prefix":"10.1016","volume":"255","author":[{"given":"Junhui","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6175-8590","authenticated-orcid":false,"given":"Yanfeng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6750-1465","authenticated-orcid":false,"given":"Hang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9034-5755","authenticated-orcid":false,"given":"Sandra","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2026.106537_bib1","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJMoa1404505","article-title":"Emergence of Zaire Ebola virus disease in Guinea","volume":"371","author":"Baize","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2026.106537_bib2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1126\/science.1172705","article-title":"Discovery of swine as a host for the Reston ebolavirus","volume":"325","author":"Barrette","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2026.106537_bib3","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.aad5788","article-title":"Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak","volume":"351","author":"Bornholdt","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2026.106537_bib4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12916-023-02847-1","article-title":"Sudan Ebola virus (SUDV) outbreak in Uganda, 2022: lessons learnt and future priorities for Sub-Saharan Africa","volume":"21","author":"Bwire","year":"2023","journal-title":"BMC Med."},{"key":"10.1016\/j.antiviral.2026.106537_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1745-7270.2005.00101.x","article-title":"Vaccination against very virulent infectious bursal disease virus using recombinant T4 bacteriophage displaying viral protein VP2","volume":"37","author":"Cao","year":"2005","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.antiviral.2026.106537_bib6","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200206","article-title":"Deciphering and predicting CD4+ T cell immunodominance of influenza virus hemagglutinin","volume":"217","author":"Cassotta","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2026.106537_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01242-23","article-title":"Delayed treatment of cynomolgus macaques with a FVM04\/CA45 monoclonal antibody cocktail provides complete protection against lethal Sudan virus infection","volume":"98","author":"Chan","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106537_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.128837","article-title":"Recombinant bacteriophage T4 displaying key epitopes of the foot-and-mouth disease virus as a novel nanoparticle vaccine","volume":"258","author":"Chen","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.antiviral.2026.106537_bib9","article-title":"Immunogenicity of an extended dose interval for the Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen in adults and children in the democratic Republic of the Congo","volume":"12","author":"Choi","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.antiviral.2026.106537_bib10","first-page":"247","article-title":"1976. Report of a WHO\/International study team","volume":"56","year":"1978","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.antiviral.2026.106537_bib11","first-page":"271","volume":"56","year":"1978","journal-title":"1976. Bull World Health Organ"},{"key":"10.1016\/j.antiviral.2026.106537_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004509","article-title":"Shed GP of Ebola virus triggers immune activation and increased vascular permeability","volume":"10","author":"Escudero-P\u00e9rez","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2026.106537_bib13","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2203272119","article-title":"Structures of a large prolate virus capsid in unexpanded and expanded states generate insights into the icosahedral virus assembly","volume":"119","author":"Fang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2026.106537_bib14","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJMra1901594","article-title":"Ebola","volume":"382","author":"Feldmann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2026.106537_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105851","article-title":"Broad antibody and T cell responses to Ebola, Sudan, and Bundibugyo ebolaviruses using mono- and multi-valent adjuvanted glycoprotein vaccines","volume":"225","author":"Felgner","year":"2024","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106537_bib16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cell.2015.12.022","article-title":"Cross-reactive and potent neutralizing antibody responses in human survivors of natural ebolavirus infection","volume":"164","author":"Flyak","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2026.106537_bib17","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1073\/pnas.0400444101","article-title":"Molecular architecture of the prolate head of bacteriophage T4","volume":"101","author":"Fokine","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2026.106537_bib18","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00203-014-0989-8","article-title":"T4 bacteriophage as a phage display platform","volume":"196","author":"Gamkrelidze","year":"2014","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.antiviral.2026.106537_bib19","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41564-018-0227-2","article-title":"The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses","volume":"3","author":"Goldstein","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.antiviral.2026.106537_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2026.106537_bib21","article-title":"Molecular analysis of the 2012 Bundibugyo virus disease outbreak","volume":"2","author":"Hulseberg","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.antiviral.2026.106537_bib22","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.1128\/JVI.00322-16","article-title":"Both epistasis and diversifying selection drive the structural evolution of the Ebola virus glycoprotein mucin-like domain","volume":"90","author":"Ibeh","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106537_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-020-0147-3","article-title":"Ebola virus disease","volume":"6","author":"Jacob","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.antiviral.2026.106537_bib24","doi-asserted-by":"crossref","first-page":"12463","DOI":"10.1128\/JVI.76.24.12463-12472.2002","article-title":"Covalent modifications of the ebola virus glycoprotein","volume":"76","author":"Jeffers","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106537_bib26","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41590-026-02459-w","article-title":"Improved VSV-Ebola-GP booster vaccination approach promotes antibody affinity maturation and durable anti-Ebola immunity in humans","volume":"27","author":"Khurana","year":"2026","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2026.106537_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01845-18","article-title":"Antibody-mediated protective mechanisms induced by a trivalent Parainfluenza virus-vectored Ebolavirus vaccine","volume":"93","author":"Kimble","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106537_bib28","article-title":"Filovirus disease outbreaks: a chronological overview","volume":"10","author":"Languon","year":"2019","journal-title":"Virology (Auckl)"},{"key":"10.1016\/j.antiviral.2026.106537_bib29","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0140-6736(95)90925-7","article-title":"Isolation and partial characterisation of a new strain of Ebola virus","volume":"345","author":"Le Guenno","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2026.106537_bib31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature07082","article-title":"Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor","volume":"454","author":"Lee","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2026.106537_bib30","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2217\/fvl.09.56","article-title":"Ebolavirus glycoprotein structure and mechanism of entry","volume":"4","author":"Lee","year":"2009","journal-title":"Future Virol."},{"key":"10.1016\/j.antiviral.2026.106537_bib32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41541-023-00699-7","article-title":"YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge","volume":"8","author":"Lemmens","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.antiviral.2026.106537_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00862-13","article-title":"Comprehensive functional analysis of N-linked glycans on Ebola virus GP1","volume":"5","author":"Lennemann","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2026.106537_bib34","article-title":"Bacteriophage T4 vaccine platform for next-generation influenza vaccine development","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.antiviral.2026.106537_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105688","article-title":"T4 bacteriophage nanoparticles engineered through CRISPR provide a versatile platform for rapid development of flu mucosal vaccines","volume":"217","author":"Li","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106537_bib36","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(18)33132-5","article-title":"Ebola virus disease","volume":"393","author":"Malvy","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2026.106537_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2016.09.001","article-title":"Filovirus proteins for antiviral drug discovery: a structure\/function analysis of surface glycoproteins and virus entry","volume":"135","author":"Martin","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106537_bib38","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/14760584.2020.1738225","article-title":"The Ebola virus glycoprotein and its immune responses across multiple vaccine platforms","volume":"19","author":"O'Donnell","year":"2020","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.antiviral.2026.106537_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.942897","article-title":"Multimerization of Ebola GP\u0394mucin on protein nanoparticle vaccines has minimal effect on elicitation of neutralizing antibodies","volume":"13","author":"Powell","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.antiviral.2026.106537_bib40","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221654","article-title":"A cell-free antigen processing system informs HIV-1 epitope selection and vaccine design","volume":"220","author":"Sengupta","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2026.106537_bib41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-1-4614-7651-1_5","article-title":"Filovirus entry","volume":"790","author":"Simmons","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.antiviral.2026.106537_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01926-18","article-title":"A bacteriophage T4 nanoparticle-based dual vaccine against anthrax and plague","volume":"9","author":"Tao","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2026.106537_bib43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.addr.2018.06.025","article-title":"Bacteriophage T4 nanoparticles for vaccine delivery against infectious diseases","volume":"145","author":"Tao","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.antiviral.2026.106537_bib44","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1473-3099(20)30016-5","article-title":"Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial","volume":"20","author":"Tapia","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2026.106537_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000212","article-title":"Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda","volume":"4","author":"Towner","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2026.106537_bib46","doi-asserted-by":"crossref","first-page":"10958","DOI":"10.1128\/JVI.00870-14","article-title":"Spatial localization of the Ebola virus glycoprotein mucin-like domain determined by cryo-electron tomography","volume":"88","author":"Tran","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106537_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105889","article-title":"Safety, tolerability, immunogenicity, and plasmapheresis-based antibody collection in a phase 1b open label trial of two investigational monovalent chimpanzee adenoviral vectored filovirus vaccines, cAd3-Sudan and cAd3-Marburg, in healthy adults","volume":"119","author":"Vert-Wong","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.antiviral.2026.106537_bib48","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.cell.2017.04.037","article-title":"Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses","volume":"169","author":"Wec","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2026.106537_bib49","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/978-1-4939-3387-7_12","article-title":"Designing efficacious vesicular stomatitis virus-vectored vaccines against Ebola virus","volume":"1403","author":"Wong","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2026.106537_bib50","doi-asserted-by":"crossref","first-page":"S660","DOI":"10.1093\/infdis\/jiad157","article-title":"A highly attenuated panfilovirus VesiculoVax vaccine rapidly protects nonhuman Primates against Marburg virus and 3 species of Ebola virus","volume":"228","author":"Woolsey","year":"2023","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2026.106537_bib51","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.virs.2024.03.010","article-title":"Establishment and application of a surrogate model for human Ebola virus disease in BSL-2 laboratory","volume":"39","author":"Yang","year":"2024","journal-title":"Virol. Sin."},{"key":"10.1016\/j.antiviral.2026.106537_bib53","first-page":"1003","article-title":"Lethal VSV-based surrogate mouse models for Sudan and Bundibugyo ebolaviruses enable antibody evaluation under BSL-2 conditions","volume":"47","author":"Zhang","year":"2026","journal-title":"Zool. Res."},{"key":"10.1016\/j.antiviral.2026.106537_bib52","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1016\/j.ymthe.2024.08.026","article-title":"Rational design of self-amplifying virus-like vesicles with Ebola virus glycoprotein as vaccines","volume":"32","author":"Zhang","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2026.106537_bib54","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.1016\/j.ymthe.2025.08.022","article-title":"Recombinant live attenuated measles virus-based vaccines inducing comprehensive protection against Ebola and Marburg viruses","volume":"33","author":"Zhou","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2026.106537_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh1547","article-title":"A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering","volume":"7","author":"Zhu","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.antiviral.2026.106537_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01822-22","article-title":"A bacteriophage-based, highly efficacious, Needle- and adjuvant-free, mucosal COVID-19 vaccine","volume":"13","author":"Zhu","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2026.106537_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/smsc.202570016","article-title":"A modular bacteriophage T4 nanoparticle platform enables rapid design of dual COVID-19-Flu mucosal vaccines","volume":"5","author":"Zhu","year":"2025","journal-title":"Small Sci."},{"key":"10.1016\/j.antiviral.2026.106537_bib58","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-virology-111821-111145","article-title":"Bacteriophage T4 as a protein-based, Adjuvant- and needle-free, mucosal pandemic vaccine design platform","volume":"11","author":"Zhu","year":"2024","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.antiviral.2026.106537_bib57","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1021\/acssynbio.2c00041","article-title":"Combining CRISPR-Cpf1 and recombineering facilitates fast and efficient genome editing in Escherichia coli","volume":"11","author":"Zhu","year":"2022","journal-title":"ACS Synth. Biol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226001968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226001968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T21:24:42Z","timestamp":1794086682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354226001968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":58,"alternative-id":["S0166354226001968"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106537","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A self-adjuvant trivalent T4 bacteriophage nanoparticle vaccine induces broad protective immunity against Orthoebolaviruses","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106537","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106537"}}